COPD

How AZ’s respiratory wins are ramping up for a bigger prize in COPD
Pharma Voice
Tue, 10/29/24 - 10:57 am
AstraZeneca
COPD
Fasenra
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Regeneron
Sanofi
Dupixent
COPD
FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Sanofi
Regeneron
Dupixent
COPD
China
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
Pharmaphorum
Thu, 09/19/24 - 09:21 am
GSK
COPD
ICER
drug pricing
Medicare
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
AstraZeneca eyes up transition to eco-friendly inhaler propellant
Clinical Trials Arena
Tue, 09/10/24 - 08:40 am
AstraZeneca
clinical trials
COPD
Breztri
environmental concerns
AstraZeneca execs 'not worried' after IL-33 drug fails to improve COPD breathing in phase 2
Fierce Biotech
Sun, 09/8/24 - 11:35 pm
AstraZeneca
tozorakimab
COPD
clinical trials
GSK says Nucala hits the target in new COPD trial
Pharmaphorum
Fri, 09/6/24 - 10:46 am
GSK
COPD
Nucala
clinical trials
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
FDA approves Verona Pharma's inhaled COPD therapy
Reuters
Thu, 06/27/24 - 11:35 am
Verona Pharma
FDA
COPD
Ohtuvayre
Verona Gears Up for First Novel COPD Approval in Over a Decade
BioSpace
Tue, 06/25/24 - 11:12 am
Verona Pharma
COPD
ensifentrine
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Where competition is heating up in pharma
Pharma Voice
Fri, 05/24/24 - 11:06 am
competition
oncology
immunology
COPD
RSV
ulcerative colitis
GSK
JNJ
Moderna Therapeutics
AstraZeneca’s Fasenra asthma drug shows promise for COPD treatment
Biopharma Reporter
Tue, 05/21/24 - 11:27 am
AstraZeneca
COPD
Fasenra
clinical trials
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Amgen
AstraZeneca
COPD
Sanofi
Regeneron
Tezspire
Dupixent
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
Fierce Biotech
Wed, 05/15/24 - 11:21 am
Blackstone Life Sciences
Uniquity Bio
solrikitug
COPD
asthma
Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch
BioSpace
Fri, 05/10/24 - 11:28 am
Verona Pharma
funding
COPD
Amgen Highlights New COPD, Asthma and Vasculitis Research at ATS 2024
BioSpace
Wed, 05/1/24 - 09:31 am
Amgen
Tezspire
COPD
AMG104
severe asthma
Tavneos
vasculitits
R&D
ATS
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
COPD
Sanofi
Regeneron
Verona Pharma
Dupixent
ensifentrine

Pages